|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Skeldon SC and Larry Goldenberg S: Bladder
cancer: A portal into mens health. Urol Oncol. 33:40–44. 2015.
View Article : Google Scholar
|
|
3
|
Sathe A and Nawroth R: Targeting the
PI3K/AKT/mTOR pathway in bladder cancer. Methods Mol Biol.
1655:335–350. 2018. View Article : Google Scholar
|
|
4
|
Zhou Y, Meng X, Chen S, Li W, Li D, Singer
R and Gu W: IMP1 regulates UCA1-mediated cell invasion through
facilitating UCA1 decay and decreasing the sponge effect of UCA1
for miR-122-5p. Breast Cancer Res. 20:322018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smolle MA and Pichler M: The role of long
non-coding RNAs in osteosarcoma. Noncoding RNA. 4:E72018.PubMed/NCBI
|
|
6
|
Ruan X: Long noncoding RNA central of
glucose homeostasis. J Cell Biochem. 117:1061–1065. 2016.
View Article : Google Scholar
|
|
7
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhai X and Xu W: Long noncoding RNA ATB
promotes proliferation, migration and invasion in bladder cancer by
suppressing microRNA-126. Oncol Res. 26:1063–1072. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu R, Zhu X, Chen F, Huang C, Ai K, Wu H,
Zhang L and Zhao X: LncRNA XIST/miR-200c regulates the stemness
properties and tumourigenicity of human bladder cancer stem
cell-like cells. Cancer Cell Int. 18:412018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peng Z, Liu C and Wu M: New insights into
long noncoding RNAs and their roles in glioma. Mol Cancer.
17:612018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Dai Q, Zeng F and Liu H: MALAT1
Promotes the proliferation and metastasis of osteosarcoma cells by
activating the Rac1/JNK pathway via targeting miR-509. Oncol Res.
Apr 27–2018.Epub ahead of print. View Article : Google Scholar
|
|
12
|
Liu S, Song L, Zeng S and Zhang L:
MALAT1-miR-124-RBG2 axis is involved in growth and invasion of
HR-HPV-positive cervical cancer cells. Tumour Biol. 37:633–640.
2016. View Article : Google Scholar
|
|
13
|
Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L,
Sun J, Cai J, Qin J, Ren J and Li Q: Resveratrol inhibits invasion
and metastasis of colorectal cancer cells via MALAT1 mediated
Wnt/beta-catenin signal pathway. PLoS One. 8:e787002013. View Article : Google Scholar
|
|
14
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li C, Cui Y, Liu LF, Ren WB, Li QQ, Zhou
X, Li YL, Li Y, Bai XY and Zu XB: High expression of long noncoding
RNA MALAT1 indicates a poor prognosis and promotes clinical
progression and metastasis in bladder cancer. Clin Genitourin
Cancer. 15:570–576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie H, Liao X, Chen Z, Fang Y, He A, Zhong
Y, Gao Q, Xiao H, Li J, Huang W and Liu Y: LncRNA MALAT1 inhibits
apoptosis and promotes invasion by antagonizing miR-125b in bladder
cancer cells. J Cancer. 8:3803–3811. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garg D and Cohen SM: miRNAs and aging: A
genetic perspective. Ageing Res Rev. 17:3–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boon RA and Vickers KC: Intercellular
transport of microRNAs. Arterioscler Thromb Vasc Biol. 33:186–192.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma ZL, Hou PP, Li YL, Wang DT, Yuan TW,
Wei JL, Zhao BT, Lou JT, Zhao XT, Jin Y and Jin YX: MicroRNA-34a
inhibits the proliferation and promotes the apoptosis of non-small
cell lung cancer H1299 cell line by targeting TGFbetaR2. Tumour
Biol. 36:2481–2490. 2015. View Article : Google Scholar
|
|
23
|
Wu X, Zhong D, Gao Q, Zhai W, Ding Z and
Wu J: MicroRNA-34a inhibits human osteosarcoma proliferation by
downregulating ether a go-go 1 expression. Int J Med Sci.
10:676–682. 2013. View Article : Google Scholar :
|
|
24
|
Yu G, Yao W, Xiao W, Li H, Xu H and Lang
B: MicroRNA-34a functions as an anti-metastatic microRNA and
suppresses angiogenesis in bladder cancer by directly targeting
CD44. J Exp Clin Cancer Res. 33:7792014. View Article : Google Scholar
|
|
25
|
Sun H, Tian J, Xian W, Xie T and Yang X:
miR-34a inhibits proliferation and invasion of bladder cancer cells
by targeting orphan nuclear receptor HNF4G. Dis Markers.
2015:8792542015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Wang M, Guo C, Wang L, Luo G, Huang C, Li
Y, Liu D, Zeng F, Jiang G and Xiao X: Long noncoding RNA GAS5
promotes bladder cancer cells apoptosis through inhibiting EZH2
transcription. Cell Death Dis. 9:2382018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiao D, Li Z, Zhu M, Wang Y, Wu G and Han
X: LncRNA MALAT1 promotes tumor growth and metastasis by targeting
miR-124/foxq1 in bladder transitional cell carcinoma (BTCC). Am J
Cancer Res. 8:748–760. 2018.PubMed/NCBI
|
|
29
|
Xie CH, Cao YM, Huang Y, Shi QW, Guo JH,
Fan ZW, Li JG, Chen BW and Wu BY: Long non-coding RNA TUG1
contributes to tumorigenesis of human osteosarcoma by sponging
miR-9-5p and regulating POU2F1 expression. Tumour Biol.
37:15031–15041. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li C, Wan L, Liu Z, Xu G, Wang S, Su Z,
Zhang Y, Zhang C, Liu X, Lei Z and Zhang HT: Long non-coding RNA
XIST promotes TGF-beta-induced epithelial-mesenchymal transition by
regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Cancer Lett. 418:185–195. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan G, Wang X, Yang M, Lu L and Zhou Q:
Long non-coding RNA TUG1 promotes progression of oral squamous cell
carcinoma through upregulating FMNL2 by sponging miR-219. Am J
Cancer Res. 7:1899–1912. 2017.PubMed/NCBI
|
|
32
|
Ye J, Li L, Feng P, Wan J and Li J:
Downregulation of miR-34a contributes to the proliferation and
migration of laryngeal carcinoma cells by targeting cyclin D1.
Oncol Rep. 36:390–398. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R,
Sun Z and Zheng X: Downregulation of CCND1 and CDK6 by miR-34a
induces cell cycle arrest. FEBS Lett. 582:1564–1568. 2008.
View Article : Google Scholar : PubMed/NCBI
|
